Palatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL8177
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...
Medindia2d
Palatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity Study
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...
Morningstar5d
Palatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL8177
Orally administered PL8177 is designed to target melanocortin-1 receptors on the surface of cells lining the colon. In a Phase 1 clinical trial, the oral version of PL8177 was shown to effectively ...
The Pharma Letter1d
Palatin touts Phase II obesity study results
US drug developer Palatin Technologies (NYSE American: PTN) announced that its BMT-801 Phase II obesity co-administration ...
Palatin says BMT-801 Phase 2 obesity study met primary endpoint
Technologies announced that its BMT-801 Phase 2 obesity co-administration study met its primary endpoint and was highly ...
Stockhead on MSN1d
Biocurious: While other biotechs scratch around for cash, Clinuvel is accused of having too much
Corporate investor briefings are normally civil affairs, but in the case of skin disorders specialist Clinuvel ...
Palatin reports ‘positive’ results from Phase 2 study of PL8177
Technologies announced positive topline results from its Phase 2 study of PL8177, a selective melanocortin-1 receptor agonist, in ...
Perspective Therapeutics (NYSE:CATX) Earns “Buy” Rating from HC Wainwright
Perspective Therapeutics (NYSE:CATX – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research ...
Le Lézard5d
National Triglyceride Alliance Launches to Advance Clinician Education on High Triglycerides and the Importance of Proactive Triglyceride Management
The National Triglyceride Alliance (NTA) is proud to announce its official launch, marking a pivotal step in advancing education and awareness about the critical role of triglycerides in metabolic ...
Le Lézard5d
Korea Zinc Announces AGM Results, with the Current Management Retaining Control of the Board with Overwhelming Shareholder Support
Korea Zinc (KRX:010130) announced on March 28 that it has successfully concluded its annual general meeting (AGM), with the current management retaining board control in contention against MBK and ...